23RD IFCC-EFLM EUropean Congress of Clinical Chemistry and Laboratory Medicine National Congress of the Spanish Society of Laboratory Medicine ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
www.euromedlab2019barcelona.org
23RD IFCC-EFLM EUropean Congress of Clinical Chemistry and Laboratory Medicine
National Congress of the Spanish Society of Laboratory Medicine
PRELIMINARY programME
DEDICATED TO IMPROVING HEALTH WORLDWIDE
RX SERIES
Five reliable and cost effective
clinical chemistry analysers on which
to base your laboratory analysis,
offering accurate results first
time, every time.
QUALITY CONTROL REAGENTS
A complete laboratory The widest range of 113
QC solution comprising Third clinical biochemistry tests,
Party Controls, External Quality facilitating routine and niche
Assessment and Interlaboratory testing on hundreds of routine
Data Management. biochemistry analysers.
EVIDENCE SERIES
A range of immunoassay
analysers that guarantee cost-
effective, highly accurate and flexible
testing solutions through utilising
Biochip Array Technology.
marketing@randox.com
#ImprovingHealth randox.com/improving-health
contents
Invitations 2
Committees 5
Executive Boards 6
Congress Secretariat 6
Week Agenda 7
Opening Ceremony Programme 8
Scientific Programme 9
Satellite Meetings 24
Scholarships and Bursaries 25
Abstracts Submission: instructions and info 26
General Information 28
Registration Information 30
Hotel Information 32
List of Sponsors & Exhibitors 33
DATES TO FOCUS ON
January 15th, 2019
Deadline for poster abstract submission
March 31st, 2019
Deadline for reduced registration fees
IFCC PRESIDENT INVITATION
Professor Howard Morris
President IFCC
Dear Friends and Colleagues,
It is my great pleasure to welcome you to the 23rd European Congress of Laboratory medicine - EuroMedlab Barcelona 2019. The
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) is proud to join with European Federation of Laboratory
Medicine (EFLM) and the Spanish Society of Laboratory Medicine in organising this important event for laboratory medicine.
The IFCC, EFLM and our member societies are responsible for the professional leadership of laboratory medicine in this major region
which is experiencing significant social and technological changes. The provision of quality healthcare is a key element for every
community and nation and the practice of high quality laboratory medicine is a major contributor to the provision of optimal healthcare.
This congress has a high degree of responsibility to inspire and train healthcare professionals to provide the highest level of service to
support their communities. Laboratory medicine specialists and the diagnostic industry working together converting data into knowledge
add value to healthcare and improve patient outcomes.
Whatever our field of laboratory medicine or work environment, it is important that we regularly come together to discuss, debate and
decide on the best practice for laboratory medicine to improve the quality of healthcare for our patients and our communities. This
EuroMedlab Congress provides an excellent opportunity by addressing the important current topics covering the range of scientific
and technological aspects of laboratory medicine with participants from all over the region and many from further afield. Our corporate
members and their colleagues in the In Vitro Diagnostics industry will play a key role bringing the latest technologies and contributing to
education. This congress will provide excellent opportunities for establish necessary networks for developing your potential to its fullest
in this rewarding profession.
I wish all delegates an enjoyable and productive congress in this historic and significant region of the world for all peoples,
Yours sincerely,
Professor Howard Morris, President IFCC
2
SECQ PRESIDENT INVITATION
Dr. Imma Caballé
President Congress and Spanish Society of Laboratory Medicine
Dear Colleagues and Friends,
On behalf of the Spanish Society of Laboratory Medicine (SEQCML) it is my great pleasure to invite you to the 23rd IFCC-EFLM
European Congress of Laboratory Medicine, from May 19th to May 23rd 2019 in Barcelona.
SEQCML has always taken great pride in organising its congresses with an active participation of around 1000 delegates and the
pleasing feature of a high number of young attendees. At the present time, our Society, founded 40 years ago, has a total of 2565
members, of which 335 are trainees in Laboratory Medicine. SEQCML organises five Annual Educational Programmes with more than
2000 participants and an extensive EQAS programme distributed among 700 participating centres with a total of 5000 registrants. Our
Society’s Strategic Plan proposes several strategic initiatives, among which the following stand out: promoting the value of the clinical
laboratory, promoting excellence in scientific-technical activities, improving its members´ perception of Society activities, making the
SEQCML visible in society in general, and promoting generational change.
EuroMedLab Barcelona 2019 will offer a few days of intense activity with a stimulating scientific programme including plenary lectures,
symposia, educational workshops and interactive poster sessions, which will provide participants with a platform for academic exchange
on exciting new topics, along with the Europe’s largest commercial exhibition of in-vitro diagnostic products.
The Congress venue, the Barcelona International Convention Centre (CCIB) is in Diagonal Mar, the newest section of Barcelona’s
seafront in the heart of the technology and business district known as Barcelona 22@, and very well-connected to the city centre.
Barcelona, one of the most vibrant cities in Europe, has the dynamic and open personality so typical of Mediterranean cities. Barcelona
has its own way of life that makes it unique. It is the perfect city to relax in, stroll around, and enjoy.
We are sure that both the scientific and the cultural programmes will provide you a wonderful opportunity to learn and hear from experts,
to share your knowledge, to develop and strengthen relationships with peers, and to take home enjoyable and valuable memories.We
sincerely hope to see you in Barcelona in May 2019
With warmest regards,
Dr. Imma Caballé
President Congress and Spanish Society of Laboratory Medicine
3
EFLM PRESIDENT INVITATION
Professor Neumaier
EFLM President
Dear Colleagues and Friends,
it is my great pleasure to invite you to the EUROMEDLAB 2019, the IFCC-EFLM European Conference for Clinical Chemistry and
Laboratory Medicine to be held in Barcelona, Spain from the 19th to 23rd of May of next year.
Like in the preceding successful EUROMEDLAB congresses, Barcelona will see a central gathering of specialists from the medical
diagnostic laboratory. We all look forward to welcoming thousands of participants from all parts of the world representing medicine,
science and the diagnostic industry.
With one year to go before the opening ceremony of the “EUROMEDLAB 2019” in Barcelona, the preparations are well under way and an
exciting programme is taking shape to address many important topics of laboratory diagnostics in health care and research. These topics
cover both current state-of-the-art and continuous developments of today´s modern laboratory, but also shall provide seminal insights
into concepts and potentials of a presumed future evolution in the field of Clinical Chemistry and Laboratory Medicine. A broad range of
international speakers, key opinion leaders and stakeholders will bring these developments to life discussing important issues around
health care, scientific advances, professional matters.
Laboratory Medicine has always been the cross-sectional discipline setting the pace for progress in many areas of modern medicine by
thoroughly implementing analytical innovation and professional practice in the medical diagnostic laboratory, and she will continue to
do so in the future. Furthermore, we are now heading into the exciting and challenging times of the era of digital health and digitalized
medicine that will have the greatest impact on “the what” and “the how” of diagnostic service and expertise that the medical laboratory
will provide in future health care. This includes new and extended means of integration and interpretation of laboratory data into the
clinical process, and this will change our medical dialogue. Laboratory Medicine also will need to reflect potential future relationships
with stakeholders outside the realm of the professional dialogue like the empowered patient in the context of patient-oriented laboratory
medicine.
Foreseeably, the tasks for Laboratory Medicine beyond the established scope of a technical profession will become more complex in the
future and will require us to set and adjust standards for our curricular education and training programs in order to sustainably attract the
young generation of professionals with an interest in our multifaceted field of technical, analytical and medical expertise.
I am certain that the high quality programme of EUROMEDLAB 2019 will reflect this and will provide you with ample opportunities for
invigorating old contacts, making new ones and having fruitful discussions during the coming EUROMEDLAB.
We hope to see you all in Barcelona
Prof. Michael Neumaier
EFLM President
Member of the Organizing Committee
4COMMITTEES
CONGRESS ORGANISING COMMITTEE
Maurizio Ferrari, Chair
Imma Caballé, Congress President
Eric Kilpatrick, SPC Chair
Ralf Lichtinghagen
Stefano Montalbetti
Michael Neumaier
José Queralto
Jaime Vives
James Wesenberg
SCIENTIFIC PROGRAMME COMMITTEE
Eric Kilpatrick, Chair
Sergio Bernardini
Antonio Buño Soto
Imma Caballé, Congress President
Damien Gruson
Sverre Sandberg
Ian Young
INTERNATIONAL SCIENTIFIC ADVISORY BOARD
Andrea Griesmacher (Austria)
Radivoj Jadric (Bosnia Herzegovina)
Kamen Tzatchev (Bulgaria)
Daria Pašalić (Croatia)
Spyroula Christou (Cyprus)
Richard Prusa (Czech Republic)
Liisa Kuhi (Estonia)
Anna Linko-Parvinen (Finland)
Michel Vaubourdolle (France)
Michael Vogeser (Germany)
Katherina Psarra (Greece)
Ajzner Éva (Hungary)
Ingunn Thorsteinsdottir (Iceland)
Marielle Kaplan (Israel)
Giuseppe Lippi (Italy)
Dalius Vitkus (Lithuania)
Sonja Kuzmanovska (Macedonia)
Robert de Jonge (Netherlands)
Anne Lise Bjørke Monsen (Norway)
Katarzyna Fischer (Poland)
Henrique Reguengo (Portugal)
Zorica Sumarac (Serbia)
Gustáv Kováč (Slovak Republic)
Evgenija Homsak (Slovenia)
Antonio Buño Soto (Spain)
Mats Ohlson (Sweden)
Michel F. Rossier (Switzerland)
Dogan Yucel (Turkey)
Maurice O’Kane (United Kingdom)
5executive boards
IFCC EXECUTIVE BOARD
Howard Morris, President
Maurizio Ferrari, Past President
David Kinniburgh, Secretary
Tomris Ozben, Treasurer
Rolf Hinzmann, Corporate Rep.
Adekunle B Okesina, African Federation of Clinical Chemistry (AFCC)
Abderrazek Hedhili, Arab Federation of Clinical Biology (AFCB)
Sunil Sethi, Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB)
Sverre Sandberg, European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
Rosa Sierra-Amor, Latin-American Confederation of Clinical Biochemistry (COLABIOCLI)
Ann Gronowski, North American Federation of Clinical Chemistry and Laboratory Medicine (NAFCC)
EFLM EXECUTIVE BOARD
Michael Neumaier, President
Sverre Sandberg, Past President
Ana-Maria Simundic, President-Elect
Giuseppe Lippi, Secretary
Huibert Storm, Treasurer
Joao Tiago Guimaraes, Member-at-Large
Tomas Zima, Member-at-Large
SEQC EXECUTIVE BOARD congress secretariat
Imma Caballé, President
Francisco Bernabeu, Vice-president
José Ángel Cocho, Treasurer
Josefina Mora, Secretary
Antonio Buño, Member
Antonio Moreno, Member
Ángeles Giménez, Member
Álvaro González, Member
Dolors Balsells, Member MZ Congressi s.r.l.
Member of the MZ International Group
Individual Company subject to management
and coordination by MZ International Group s.r.l.
Via Carlo Farini 81- 20159 Milano (Italy)
Phone: +39 02 66802323 - Fax: +39 02 6686699
info@euromedlab2019barcelona.org
For information on any specific topic,
please refer to the following e-mails:
General information: info@euromedlab2019barcelona.org
Abstracts & Posters (information only): posters@euromedlab2019barcelona.org
Companies: companies@euromedlab2019barcelona.org
Registrations: registrations@euromedlab2019barcelona.org
Scientific programme & speakers: speakers@euromedlab2019barcelona.org
Hotel reservation: ekurtz@kenes.com
6SUNDAY 19 MAY
MAIN HALL
17.00 - 20.00 Opening Ceremony
Welcome Reception
MONDAY 20 MAY
ROOM 117 ROOM 113 ROOM 114 ROOM 115 ROOM 116 EXHIBITION HALL
09.00-10.00 PL 1
10.00-10.30 BREAK
10.30-12.30 SYM 1 SYM 2 SYM 3 SYM 4 SEQC
12.30-13.30 EDUW 1 EDUW 2 EDUW 3 EDUW 4 EDUW 5
13.30-14.45 VIEWPOINT POSTER SESSION LUNCH 10.00-17.30 EXHIBITION OPEN
14.45-15.45 EDUW 6 EDUW 7 EDUW 8 EDUW 9 EDUW 10
16.00-17.00 EDUW 11 EDUW 12 EDUW 13 EDUW 14 EDUW 15
17.00-18.00 VIEWPOINT
TUESDAY 21 MAY
ROOM 117 ROOM 113 ROOM 114 ROOM 115 ROOM 116 EXHIBITION HALL
09.00-10.00 PL 2
10.00-10.30 BREAK
10.30-12.30 SYM 5 SYM 6 SYM 7 SYM 8 SEQC
12.30-13.30 EDUW 16 EDUW 17 EDUW 18 EDUW 19 EDUW 20
13.30-14.45 VIEWPOINT POSTER SESSION LUNCH 10.00-17.30 EXHIBITION OPEN
14.45-15.45 EDUW 21 EDUW 22 EDUW 23 EDUW 24 EDUW 25
16.00-17.00 EDUW 26 EDUW 27 EDUW 28 EDUW 29 EDUW 30
17.00-18.00 VIEWPOINT
WEDNESDAY 22 MAY
ROOM 117 ROOM 113 ROOM 114 ROOM 115 ROOM 116 EXHIBITION HALL
09.00-10.00 PL 3
10.00-10.30 BREAK
10.30-12.30 SYM 9 SYM 10 SYM 11 SYM 12 SEQC
12.30-13.30 EDUW 31 EDUW 32 EDUW 33 EDUW 34 EDUW 35
13.30-14.45 VIEWPOINT POSTER SESSION LUNCH 10.00-17.30 EXHIBITION OPEN
14.45-15.45 EDUW 36 EDUW 37 EDUW 38 EDUW 39 EDUW 40
16.00-17.00 EDUW 41 EDUW 42 EDUW 43 EDUW 44 EDUW 45
17.00-18.00 VIEWPOINT
THURSDAY 23 MAY
ROOM 117 ROOM 113 ROOM 114 ROOM 115 ROOM 116
09.00-10.00 PL 4
10.00-10.30 BREAK
10.30-12.30 SYM 13 SYM 14 SYM 15 SYM 16 SYM 17
CLOSING CEREMONY
7SCIENTIFIC PROGRAMME
SUNDAY, 19 MAY
17:00-19:00
Welcome addresses
Awards Ceremony
Opening Lecture
RECENT PROGRESS ON THE MECHANISMS OF AGING AND ITS MEDICAL APPLICATIONS
M. Serrano (Spain)
19:00
Welcome Cocktail M. Serrano
20:00
Concert
Manuel Serrano obtained his PhD in 1991, from the Universidad remodeling processes during embryo development. The Serrano team
Autónoma de Madrid. From 1991 to 1996, Serrano worked in the was pioneer in the generation of genetically-modifed mice resistant to
team of David Beach in Cold Spring Harbor Laboratory, NY. During cancer and found a link between tumor suppressor genes and aging.
this period, Serrano made his most important discovery with the
identification and characterization of the gene p16, one of the most In recent years, the research interests of Manuel Serrano have
important genes for anti-cancer protection. Serrano returned to extended to metabolism and cellular reprogramming in relation to
Spain in 1997 to lead a research group, first at the National Center aging. The Serrano laboratory was first in demonstrating that cellular
of Biotechnology (CNB), and then, from 2003 to 2017, at the Spanish reprogramming into pluripotency is possible within an organism, and
National Cancer Research Center (CNIO), both in Madrid. In 2017, this discover was considered Advance of the Year 2013 by Nature
Serrano moved to the Institute for Research in Biomedicine (IRB), in Medicine. More recently, Serrano has reported in Science that in vivo
Barcelona. reprogramming is enhanced by the coexistence of tissue injury thanks
to the production of the interleukin IL-6.
Manuel Serrano is internationally recognized in the field of tumor
suppression. In addition to the discovery of p16, one of his main The focus of his laboratory is now to apply their knowledge on
discoveries has been the identification of cellular senescence senescence and reprogramming to degenerative diseases such as
as a main anti-oncogenic response. Recently, his laboratory has lung, kidney and heart fibrosis.
also shown that cellular senescence participates in several tissue
8SCIENTIFIC PROGRAMME MONDAY, 20 MAY
MONDAY, 20 MAY
9:00-10:00
Plenary Lecture
HEALTH DATA RESEARCH UK (HDR UK):
OPTIONS AND OPPORTUNITIES FOR HEALTH DATA SCIENCE
A. Morris (UK)
A. Morris
Professor of Medicine Since August 2017 ANDREW MORRIS has been the inaugural
Director of Health Data Research UK Director of Health Data Research UK, the multi-funder UK Institute for
Vice Principal, Data Science health and biomedical informatics research that will capitalise on the
University of Edinburgh UK’s renowned data resources and research strengths to transform
lives through health data science. He is seconded from his position
as Professor of Medicine, and Vice Principal of Data Science at the
University of Edinburgh, having taken up position in August 2014.
Prior to this Andrew was Dean of Medicine at the University of Dundee.
Andrew was Chief Scientist at the Scottish Government Health
Directorate (2012-2017) and has served and chaired numerous
national and international grant committees and Governmental bodies.
Andrew was awarded a CBE (Commander of the Most Excellent
Order of the British Empire) in the 2018 New Year’s Honour’s List.
His research interests span informatics and chronic diseases. He has
published over 300 original papers and has attracted over £50million
in grant funding.
9SCIENTIFIC PROGRAMME MONDAY, 20 MAY
10:00-10:30
Break
10:30-12:30
Symposium 1
NEW DEVELOPMENTS IN OLD DISEASES
Chairs: E. Kilpatrick (Quatar/UK), P. Laitinen (Finland)
E. Kilpatrick P. Laitinen
What is new in cardiac markers?
P. Laitinen (Finland)
Vitamin D for conditions other than bone disease: an update of the evidence
H. Morris (Australia)
New diabetes treatments and the role of the laboratory
S. Atkin (Qatar)
Old and new biomarkers for kidney disease
E. Cavalier (Belgium)
P. Laitinen H. Morris S. Atkin E. Cavalier
10:30-12:30
Symposium 2
POINT OF CARE TESTING. FROM QUALITY ASSURANCE STRATEGIES
TO CLINICAL UTILITY AND PATIENT OUTCOMES
Chairs: A. Buno (Spain), S. Sandberg (Norway) A. Buno S. Sandberg
Quality control and analytical performance specifications for
different clinical POCT settings. Should they be different?
S. Sandberg (Norway)
20 years’ experience on quality assurance strategies of a large and ISO 22870 accredited POCT multiparameter network
P. Oliver (Spain)
How the use of POCT has changed the clinical pathways and outcome for patients with infectious diseases in Africa
R. Erasmus (South Africa)
SensUs Student Competition: Global education and innovation in POCT
To be announced
S. Sandberg P. Oliver R. Erasmus
10SCIENTIFIC PROGRAMME MONDAY, 20 MAY
10:30-12:30
Symposium 3
PRINCIPLES AND APPLICATIONS OF EPIGENETICS
Chairs: C.Abi Khalil (Qatar, USA), J. Oriola (Spain)
C. Abi Khalil J. Oriola
Basic principles of epigenetics: DNA methylation, histone modifications and non-coding RNAs
T. Ozben (Turkey)
Epigenetics in humans: from early development to ageing
M. Fraga (Spain)
Epigenetics in diabetes and cardiovascular disease
C.Abi Khalil (Qatar, USA)
Epigenetics in advancing drug development and personalised medicine
L. Altucci (Italy)
L. Altucci T. Ozben M. Fraga C.A. Khalil
10:30-12:30
Symposium 4
ETHICAL ISSUES IN LABORATORY MEDICINE
Chair: A. González Hernández (Spain), M. O’Kane (UK)
A. González Hernández M. O’Kane
Ethical dilemmas in laboratory medicine
M.J. McQueen (Canada)
Personalised genomic medicine: ethical considerations
J.J. Jonsson (Iceland)
Ethical issues in direct-to-consumer testing
A. Cambon-Thomsen (France)
Ethical issues in biomedical publication
M. O’Kane (UK)
M.J. McQueen J.J. Jonsson A. Cambon-Thomsen M. O’Kane
11SCIENTIFIC PROGRAMME MONDAY, 20 MAY
10:30-12:30
SEQC Symposium
NEW TRENDS IN THE DIAGNOSIS OF INBORN ERRORS OF METABOLISM
Chair: H. Rocha (Portugal), R. Yahyaoui (Spain)
H. Rocha R. Yahyaoui
Precision medicine meets newborn screening: the path forward
P. Rinaldo (USA)
Untargeted metabolomics in the diagnosis of metabolic disorders
J. Jans (The Netherlands)
Inborn errors of metabolism diagnosis in Next Generation Sequencing era: opportunities and difficulties
B. Perez (Spain)
Integrative approaches for the diagnosis of
inborn errors of metabolism
H. Rocha (Portugal)
P. Rinaldo J. Jans B. Perez H. Rocha
13:30-14:45
Poster Session
13:30-14:30
Viewpoint
WHO SHOULD LEAD A MEDICAL LABORATORY?
The case for the Physician
M. Neumaier (Germany)
The case for the Technologist
M. Nora Roald (Norway)
The case for the Clinical Scientist
G. Wieringa (UK)
M. Neumaier M. Nora Roald G. Wieringa
17:00-18:00
Viewpoint
MEET THE THYROID EXPERT
Chair: C. Wiley (USA)
D. Gruson (Belgium)
C. Wiley D. Gruson
12SCIENTIFIC PROGRAMME TUESDAY, 21 MAY
TUESDAY, 21 MAY
9:00-10:00
Plenary Lecture
CANCER PHARMACO-EPIGENETICS
M. Esteller (Spain)
M.Esteller
Manel Esteller (Sant Boi de Llobregat, Barcelona, Catalonia, Spain, Author of 485 original publications in peer-reviewed scientific journals,
1968) graduated in Medicine from the Universidad de Barcelona sixteen of them categorized as “Highly Cited Paper” by Thomson
in 1992, where he also obtained his Ph.D. degree specialising in Reuters. Dr Esteller has a Total Impact Factor of 4,488.212 and a
molecular genetics of endometrial carcinoma, in 1996. He was an Total Number of Citations of 56,846, having an h-Index of 116. He is
Invited Researcher at the School of Biological and Medical Sciences also a Member of numerous international scientific societies, Editorial
at the University of St. Andrews, (Scotland, UK) during which time Boards and reviewer for many journals and funding agencies. Dr
his research interests focused on the molecular genetics of inherited Esteller is also Associate Editor for Cancer Research, The Lancet
breast cancer. From 1997 to 2001, Esteller was a Postdoctoral Oncology, Carcinogenesis, Genome Research and The Journal of The
Fellow and a Research Associate at the Johns Hopkins University National Cancer Institute. He is also Editor-in-Chief of Epigenetics.
and School of Medicine, (Baltimore, USA) where he studied DNA
methylation and human cancer. His work was decisive in establishing His work has received, among other, the Carcinogenesis Award
promoter hypermethylation of tumour suppressor genes as a common (2005), Beckman-Coulter Award (2006), Fondazione Piemontese
hallmark of all human tumours. From October 2001 to September per la Ricerca sul Cancro (FPRC) Award (2006), Swiss Bridge Award
2008 Manel Esteller was the Leader of the CNIO Cancer Epigenetics (2006), Innovation Award from the Commonwealth of Massachussets
Laboratory, where his principal area of research were the alterations (2007), Human Frontier Science Program Award (2007), DEbiopharm-
in DNA methylation, histone modifications and chromatin in human EPFL Award (2009), Dr. Josef Steiner Cancer Research Award
cancer. Since October 2008, Dr Esteller is the Director of the Cancer (2009), Lilly Foundation Preclinical Biomedical Research Award
Epigenetics and Biology Program (PEBC) of the Bellvitge Institute for (2009), World Health Summit Award (2010), the European Research
Biomedical Research (IDIBELL) in Barcelona, Chairman of Genetics Council Advanced Grant (2011), “Rey Jaime I” Research Award
in the School of Medicine of the University of Barcelona, and an (2013), Severo Ochoa Award in Biomedicine (2014), National
ICREA Research Professor. His current research is devoted to the Award in Oncology (2014), “Dr Josep Trueta Medal” Generalitat de
establishment of the epigenome maps of normal and transformed Catalunya, Catalan Goverment (2015), National Research Award of
cells, the study of the interactions between epigenetic modifications the Catalan Goverment (2015), Gold Medal, Parlament of Catalonia
and non-coding RNAs, and the development of new epigenetic drugs (2016), International Award of Catalonia (2016), Falcó Carlemany
for cancer therapy. Award (2017) and Innovation in Healthcare Oncology Award (2018)
13SCIENTIFIC PROGRAMME TUESDAY, 21 MAY
TUESDAY, 21 MAY
9:00-10:00
Plenary Lecture I. Caballé D. Gruson
CANCER PHARMACO-EPIGENETICS
M. Esteller (Spain)
10:30-12:30
Symposium 5
FINANCING LABORATORY MEDICINE
Chairs: I. Caballé, D. Gruson
Integrating laboratory medicine into national and hospital health budgets
T. Marti
Health Technology Assessments to support test cost effectiveness
To be announced
Broadening access for innovative diagnostic solutions
N. Farkas
Round table with speakers
T. Marti N. Farkas
10:30-12:30
Symposium 6
ADVANCES IN IN-VITRO FERTILISATION
Chairs: J. Olofsson (Sweden), C. Sanchez Pozo (Spain)
Reproductive medicine in 2019 – the 7 key Questions: J. Olofsson C. Sanchez Pozo
Who, What, Why, When, Where, How, How Much?
N. Polyzos (Spain)
Fertility preservation a look into the future
A. Arav (Israel)
Advances in ovarian stimulation regimens and monitoring during in-vitro fertilisation
J. Olofsson (Sweden)
The role of the laboratory in IVF success
J. Hreinsson (Sweden)
N. Polyzos A. Arav J. Olofsson J. Hreinsson
14SCIENTIFIC PROGRAMME TUESDAY, 21 MAY
10:30-12:30
Symposium 7
A NEW ERA IN COMMUNICATING DIAGNOSTICS DATA TO PATIENTS
Chairs: K. Adeli (Canada), M. Calvo (Spain)
K. Adeli M. Calvo
Classification and benchmarking apps for patients and professionals
S. Jovicic (Serbia)
Personalised communication of results to patients
I. Watson (UK)
Electronic apps and medical diagnostics data management
K. Adeli (Canada)
Online resources for patients and healthcare professionals
T. Pillay (South Africa)
S. Jovicic I. Watson K. Adeli T. Pillay
10:30-12:30
Symposium 8
STROKE AND CNS BIOMARKERS IN CLINICAL PRACTICE
Chairs: A. Haliassos (Greece), J. Montaner (Spain)
Stroke Biomarkers Discovery A. Haliassos J. Montaner
J. Montaner (Spain)
Guiding stroke therapy with the use of blood biomarkers
A. Bustamante (Spain)
Are stroke biomarkers ready for research and clinical use? Focus on the pre-analytical, analytical and post-analytical variability
K. Makris (Greece)
CSF Xanthochromia in the investigation of suspected subarachnoid haemorrhage
G. Burrows (UK)
J. Montaner A. Bustamante K. Makris G. Burrows
15SCIENTIFIC PROGRAMME TUESDAY, 21 MAY
10:30-12:30
SEQC Symposium
EQA PROGRAMS IN SEQCML SPAIN. ALMOST 30 YEARS’ EXPERIENCE
EVALUATING THE TOTAL TESTING PROCESS
Chairs: F. R. Bauza (Spain), C. Ricós Aguilá (Spain) F. R. Bauza C. Ricós Aguilá
Quality specifications in EQA of Total Testing Process. Is there an international agreement?
P. Fernandez-Calle (Spain)
Educative (not mandatory) EQA. Achievement of quality specifications based on biological variation. Is there a positive evolution?
C. Ricós Aguilá (Spain)
Evolution of state-of-the-art over almost 30 years: imprecision and bias detection trough EQA. Interaction among EQA organizers, IVD
and participant laboratories
C. Perich Alsina (Spain)
Evolution of quality indicators over more than 20 years.
Looking back and forward
M. Ibarz Escuer (Spain)
P.Fernandez-Calle C. Ricós Aguilá C. Perich Alsina M. Ibarz Escuer
13:30-14:15
Viewpoint
YOUNG SCIENTIST SESSION
J.M. Bauça (Spain), J.R. Bauza (Spain)
Worldwide YS groups/organizations. Different boarding models L.M. Bauça J.R. Bauza
C. Imperiali (Spain)
Publishing key points, how can I succeed publishing in top journals?
A.M. Simundic (Croatia)
Young Scientist: Career prospect, research, and networking
R. Shrestha (Japan)
C. Imperiali A.M. Simundic R. Shrestha
17:00-17:45
Viewpoint
CRISPR
L. Montoliu (Spain)
L. Montoliu
16SCIENTIFIC PROGRAMME WEDNESDAY, 22 MAY
WEDNESDAY, 22 MAY
9:00-10:00
Plenary Lecture: THE MICROBIOME AND BIODIVERSITY HYPOTHESIS OF HEALTH
T. Haahtela (Finland)
T. Haahtela
Dr Tari Haahtela is professor emeritus of clinical allergology from
University of Helsinki. He is the former Head of Skin and Allergy
Hospital, Helsinki University Hospital. He has been the Chair of the
Finnish Asthma Programme 1994-2004 and Allergy Programme 2008-
2018. Studying the environmental and lifestyle determinants of allergy
and asthma led to the so called biodiversity hypothesis of health. He
was Honorary President of the EAACI Helsinki Meeting 2017.
17SCIENTIFIC PROGRAMME WEDNESDAY, 22 MAY
WEDNESDAY, 22 MAY
10:30-12:30
Symposium 9
HAEMOGLOBIN A1c IN CLINICAL PRACTICE
Chairs: M.L. Granada (Spain), G. John (UK)
Diagnosis of Diabetes using HbA1c: More than just the glucose concentration to consider
E. English (UK)
External Quality Assessment of HbA1c; lessons learnt and future prospects for quality targets M.L. Granada G. John
C. Weykamp (Netherlands)
Should HbA1c POCT be accepted for diagnosis of Type 2 Diabetes
E. Lenters-Westra (Netherlands)
When and how is a person with Type 2 Diabetes in Remission
C. Le Roux (UK)
E. English C. Weykamp E. Lenters-Westra C. Le Roux
10:30-12:30
Symposium 10
LABORATORY MEDICINE TRAINING IN EUROPE
In partnership with the IFCC Task Force for Young Scientists
Chairs: P. Dabla (India), E. Homsak (Slovenia)
P. Dabla E. Homsak
Practical knowledge and skills management- why to participate?
E. Homsak (Slovenia)
Research opportunities & skills - gateway for career enhancement
P. Dabla (India)
Current status of training in Labs - gaps and needs
L. Parnas (USA)
European Young Scientists: Training and Career
G. Boursier (France)
E. Homsak P. Dabla L. Parnas G. Boursier
18SCIENTIFIC PROGRAMME WEDNESDAY, 22 MAY
10:30-12:30
Symposium 11
EXTERNAL QUALITY ASSURANCE IN THE DIGITAL ERA
Chairs: P. Meijer (Netherlands) A. Thomas (UK)
P. Meijer A. Thomas
The digital era: a paradigm shift in external quality assurance
A. Thomas (UK)
Challenges in EQA and POCT
A. Stavelin (Norway)
Present and future possibilities of virtual EQA
I. Juhos (Hungary)
Can patient medians replace or give additional value to the traditional external quality assessment schemes?
L. Thienpont (Belgium)
A. Thomas A. Stavelin I. Juhos L. Thienpont
10:30-12:30
Symposium 12
PREPARING THE PROFESSION FOR COMPLIANCE WITH
THE NEW IVD REGULATION 2017/746 IN EUROPE
Chairs: C. Cobbaert (Netherlands), J. Vives (Spain)
C. Cobbaert J. Vives
The new IVD Regulation 2017/746 and consequences for Laboratory Medicine
C. Cobbaert (Netherlands)
A Comprehensive Framework for Test Evaluation under the new IVD regulation
R. Horvath (Australia)
What type of Clinical Evidence and Clinical Performance Study designs are required under the new IVDR era?
P. Bossuyt (Netherlands)
Defining Clinical Performance Specifications in the new IVD era
S. Lord (Australia)
C. Cobbaert R. Horvath P. Bossuyt S. Lord
19SCIENTIFIC PROGRAMME WEDNESDAY, 22 MAY
10:30-12:30
SEQC Symposium
PERSONALISED IMMUNOSUPPRESSION TO IMPROVE CLINICAL OUTCOMES
Chairs: M. Brunet (Spain), T. van Gelder (Netherlands)
M. Brunet T. van Gelder
Monitoring tacrolimus intracellular concentrations:
would it help better predicting graft clinical outcome?
F. Lemaitre (France)
Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs
T. van Gelder (Netherlands)
Improving clinical outcome using TDM in paediatric liver transplantation
E. Frauca (Spain)
The role of biomarkers in transplantation
M. Brunet (Spain)
F. Lemaitre T. van Gelder E. Frauca M. Brunet
13:30-14:15
Viewpoint
INSTRUMENT VERIFICATION: TIME WELL SPENT?
Yes
C. Sturgeon (UK) C. Sturgeon E. Kilpatrick
No
E. Kilpatrick (Qatar/UK)
17:00-17:45
Viewpoint
DATA SECURITY: A LABORATORY PERSPECTIVE
J. Rossler (Belgium) J. Rossler
20SCIENTIFIC PROGRAMME THURSDAY, 23 MAY
THURSDAY, 23 MAY
9:00-10:00
Plenary Lecture
NONINVASIVE PRENATAL TESTING BY CELL-FREE FETAL DNA ANALYSIS:
TRANSLATING INNOVATIONS INTO CLINICAL PRACTICE
R. Chiu (Hong Kong)
P. Chiu
Rossa Chiu is the Choh-Ming Li Professor of Chemical Pathology She has continued to develop expanded applications of non-invasive
and Associate Dean (Development) at the Faculty of Medicine, The prenatal diagnostics, including approaches to assess fetal single
Chinese University of Hong Kong. She serves as the Honorary Chief gene diseases, to detect fetal de novo mutations, to decipher the
of Service of the Department of Chemical Pathology, Prince of Wales fetal genome and to assess tissue-of-origin of pathologies. To date,
Hospital, Hong Kong. Prof Chiu studied medicine at the University Prof Chiu has published over 150 peer-reviewed research articles
of Queensland, Australia and later pursued her Doctor of Philosophy and has over 250 granted patents or patent applications. Prof Chiu
studies at The Chinese University of Hong Kong. She is a Fellow has received a number of awards for her research, including the 2011
of the Royal College of Pathologists of Australasia in both Genetic International Federation of Clinical Chemistry and Laboratory Medicine
Pathology and Chemical Pathology. Prof Chiu’s research interests lie (IFCC) Young Investigator Award, the 2012 China Women in Science
in the analysis of circulating nucleic acids found in human plasma. Fellowship, the 2013 American Association of Clinical Chemistry
She has made significant contributions to the development of non- Outstanding Scientific Contributions for a Young Investigator and
invasive prenatal diagnosis which led to the worldwide introduction of the 2016 Croucher Senior Medical Research Fellowship. She has
non-invasive plasma DNA tests for Down syndrome screening. been elected to serve as Secretary to the Board of Directors of the
International Society of Prenatal Diagnosis. She was the President of
the Hong Kong Society of Clinical Chemistry between 2004 to 2005.
21SCIENTIFIC PROGRAMME THURSDAY, 23 MAY
10:30-12:30
Symposium 13
PREANALYTICAL PHASE
STILL CHALLENGING FOR LABORATORY PROFESSIONALS
Chairs: M. Ibarz (Spain), A.M. Simundic (Croatia) M. Ibarz A.M. Simundic
Hemolysis: detection and management
A.M. Simundic (Croatia)
Serum indices: simple and easy tool?
G. Lippi (Italy)
To fast or not to fast: that is the question
J. Cadamuro (Austria)
Stability studies: room for improvement
M. Cornes (UK)
A.M. Simundic G. Lippi J. Cadamuro M. Cornes
10:30-12:30
Symposium 14
DYSLIPIDAEMIA GUIDELINES IN EUROPE AND NEED FOR STANDARDIZATION
OF TRADITIONAL AND NEW CARDIOVASCULAR DISEASE BIOMARKERS –
ADDRESSING CHOLESTEROL AND BEYOND
Chairs: C. Cobbaert (Netherlands), P. Gillery (France) C. Cobbaert P. Gillery
Standardization of tests in the ISO 15189:2012 era
P. Gillery (France)
Update on Dyslipidaemia Guidelines and the rationale of Cardiovascular Disease Biomarker
M. Langlois (Belgium)
Standardization of advanced lipoprotein testing: the BioSITrace project
V. Delatour (France)
Mass spectrometry-based approach for apolipoprotein quantification and profiling
C. Cobbaert (Netherlands)
P. Gillery M. Langlois V. Delatour C. Cobbaert
22SCIENTIFIC PROGRAMME THURSDAY, 23 MAY
10:30-12:30
Symposium 15
PERFORMANCE SPECIFICATION IN LABORATORY MEDICINE
Chairs: P. Fernandez-Calle (Spain), S. Sandberg (Norway)
P. Fernandez-Calle S. Sandberg
Introduction
S. Sandberg (Norway)
How to establish performance specifications based on clinical outcome studies – practical examples
A.R. Horvath (Australia)
Are biological variation data fit for purpose? Principles for the development of the EFLM biological variation database
A. Aarsand (Norway)
Performance specifications for individual limits of biomarkers in the Athlete Biological Passport
P.E. Sottas (Switzerland)
S. Sandberg A.R. Horvath A. Aarsand P.E. Sottas
10:30-12:30
Symposium 16
BIG DATA IN LABORATORY MEDICINE
Chairs: S. Bernardini (Italy), D. Gruson (Belgium)
High-throughput technologies for gathering data S. Bernardini D. Gruson
P. Fortina (USA)
Qualitative and Quantitative Variety of Big Data
D. Gruson (Belgium)
Value of Big Data: Data relevant to the health of individuals or populations
K. Sikaris (Australia)
Emerging Technologies in the age of Big Data
L. Kricka (USA)
P. Fortina D. Gruson K. Sikaris L. Kricka
23SCIENTIFIC PROGRAMME THURSDAY, 23 MAY
10:30-12:30
SEQC Symposium
CHRONIC LIVER DISEASE: THE ROLE OF THE CLINICAL LABORATORY
Chairs: W. Jimenéz (Spain), M. Morales-Ruiz (Spain)
W. Jimenéz M.Morales-Ruiz
Diagnosis and prognosis of patients with liver fibrosis based on clinical
and laboratory parameters
M. Pinzani (UK)
Monitoring of HVB infection
F. Rodriguez Frias (Spain)
Surveillance, diagnosis and prognosis tools for hepatocellular carcinoma
J. Bruix (Spain)
Diagnosis of non-alcoholic fatty liver disease and its stages. A laboratory perspective
M. Morales-Ruiz (Spain)
M. Pinzani F. Rodriguez Frias J. Bruix M. Morales-Ruiz
12:30-13:30
CLOSING CEREMONY
Closing remarks
Euromedlab Barcelona 2019 President
IFCC President
EFLM President
Welcome to Munich
Euromedlab Munich 2021 President
24EDUCATIONAL WORKSHOPS
Educational workshops are scientific sessions held in cooperation with in vitro diagnostic industries.
Educational workshops’ scientific programmes will be available on the website starting December 2018
EduW 1 Abbott Monday 20 May 12.30-13.30
EduW 2 Beckman Coulter Monday 20 May 12.30-13.30
EduW 3 Mindray Monday 20 May 12.30-13.30
EduW 4 Roche Monday 20 May 12.30-13.30
EduW 5 Sysmex Monday 20 May 12.30-13.30
EduW 6 Beckman Coulter Monday 20 May 14.45-15.45
EduW 7 Abbott Monday 20 May 14.45-15.45
EduW 8 Siemens Monday 20 May 14.45-15.45
EduW 9 Snibe Monday 20 May 14.45-15.45
EduW 10 Randox Monday 20 May 14.45-15.45
EduW 11 Sysmex Monday 20 May 16.00-17.00
EduW 12 Thermofisher Monday 20 May 16.00-17.00
EduW 13 Siemens Monday 20 May 16.00-17.00
EduW 14 Menarini Monday 20 May 16.00-17.00
EduW 15 Binding Site Monday 20 May 16.00-17.00
EduW 16 Beckman Coulter Tuesday 21 May 12.30-13.30
EduW 17 Abbott Tuesday 21 May 12.30-13.30
EduW 18 Mindray Tuesday 21 May 12.30-13.30
EduW 19 Roche Tuesday 21 May 12.30-13.30
EduW 20 Randox Tuesday 21 May 12.30-13.30
EduW 21 Randox Tuesday 21 May 14.45-15.45
EduW 22 Sysmex Tuesday 21 May 14.45-15.45
EduW 23 Siemens Tuesday 21 May 14.45-15.45
EduW 24 Snibe Tuesday 21 May 14.45-15.45
EduW 25 Sebia Tuesday 21 May 14.45-15.45
EduW 26 Gentian Tuesday 21 May 16.00-17.00
EduW 27 Biorad Tuesday 21 May 16.00-17.00
EduW 28 Siemens Tuesday 21 May 16.00-17.00
EduW 29 Horiba Tuesday 21 May 16.00-17.00
EduW 30 Fujirebio Tuesday 21 May 16.00-17.00
EduW 31 Siemens Wednesday 22 May 12.30-13.30
EduW 32 BD Wednesday 22 May 12.30-13.30
EduW 33 Ortho Clinical Diag. Wednesday 22 May 12.30-13.30
EduW 34 Roche Wednesday 22 May 12.30-13.30
EduW 35 Buhlmann Wednesday 22 May 12.30-13.30
EduW 37 Diasorin Wednesday 22 May 14.45-15.45
EduW 38 Tosoh Wednesday 22 May 14.45-15.45
25SATELLITE MEETINGS
SATURDAY, 18 MAY
VII International Symposium
LABORATORY MEDICINE AND QUALITY
At the following link scientific programme and details: https://bit.ly/2JEmfdE
SUNDAY, 19 MAY
Pre Congress Symposium
STANDARDIZATION AND RECOMMENDATIONS IN THE LABORATORY OF HAEMATOLOGY
At the following link scientific programme and details: https://bit.ly/2JlbIF7
Pre Congress Symposium
BREAST CANCER AND ENVIRONMENT
At the following link scientific programme and details: https://bit.ly/2sFz51I
ORGANISING SECRETARIAT
Sociedad Española de Medicina de Laboratorio
C/ Padilla, 323 Despacho 68 08025 Barcelona
www.seqc.es
26SCHOLARSHIPS and BURSARIES
IFCC Travel Scholarships
IFCC is pleased to offer a limited number of Travel Scholarships for the participation of
Young Scientists from developing countries to the 23rd IFCC-EFLM European Congress
of Clinical and Laboratory Medicine 2019, to be held in Barcelona – ES, 19 - 23 May 2019.
Applicants from selected countries should be less than 40y of age on 1 January 2019.
Priority will be given to persons submitting an abstract (deadline for abstract submission
15th January, 2019).
The IFCC Roche Travel Scholarship will provide funding towards the cost of economy travel
and accommodation. In addition, scholarship recipients will receive free registration from
the Congress Organising Committee.
Applicants will be required to complete the application form that can be obtained from the
IFCC Office (ifcc@ifcc.org). Applications should be submitted to the IFCC Office within: 31st
January, 2019.
For further information, please contact: ifcc@ifcc.org
EFLM Bursary Programme
This is to announce that EFLM is promoting a bursary programme for young scientists
attending the 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory
Medicine - EuroMedLab 2019 to be held in Barcelona on 19-23 May 2019.
10 bursaries are available to cover the cost of the travel and 4-night accommodation
for a maximum of Eur 900. EFLM bursary recipients will also receive the free congress
registration, kindly offered by the Congress Organizer Committee, and a free on-line yearly
subscription to the journal CCLM, kindly offered by de Gruyter.
Eligible candidates must be from an EFLM Member Society and meet the following
criteria:
■ Young participants (≤35y at the date of the congress);
■ Having a poster abstract accepted as First Author
(deadline for abstract submission January 15, 2019)
Applications must be submitted through a proper application form (downloadable from the
EFLM website) and accompanied by the following documentation:
1) Copy of the ID or passport,
2) Document proving the membership to the National Society,
3) Notification of poster acceptance (acceptance/rejection will be sent by the conference
organizers within February 28)
Applications have to be sent to silvia.cattaneo@eflm.eu within March 10, 2019.
27ABSTRACT SUBMISSION
Congress delegates are cordially invited to submit abstracts of their scientific work for presentation as a free communication at Euromedlab
Barcelona 2019. An unlimited number of abstracts may be submitted provided the presenting author applies for “full registration”.
Abstracts are welcome in all fields of clinical chemistry, haematology, clinical molecular biology and laboratory medicine, in the broader
sense. Free communications are primarily presented via poster.
ABSTRACT TOPICS
Advanced technologies, including new biomarker discovery
Analytical technologies and applications
Atherosclerosis, including lipids and other risk markers
Audit
Autoimmune diseases, including allergy
Bioinformatics, including data management
Biomarkers in cancer
Bone metabolism
Cardiovascular diseases, including cardiac markers
Case report
Clinical Studies - Outcomes
Diabetes, obesity, metabolic syndrome
Education and Training in Laboratory Medicine
Endocrinology, not including diabetes
Evidence based medicine, including Guidelines
Gastrointestinal diseases, including hepatic and pancreatic
diseases
Haematology, including haemostasis
Inflammation, vascular biology, endothelium, and oxidative stress
Inherited disorders, metabolic disorders and rare diseases
Kidney diseases
Laboratory and Sports medicine GENERAL REQUIREMENTS
Laboratory Management, Accreditation, Quality Assurance
Microbiology - Infectious diseases The text must be clear, concise, and
Molecular diagnostics, including epigenetics written in proper English.
Neonatal and paediatric laboratory medicine, including prenatal The content must not have been
testing previously published in academic
Neurological diseases journals or subject to peer review.
Nutrition, including vitamins and trace elements Significant technical information must
Personalised Medicine, including pharmacogenetics not be withheld.
Point of Care testing, critical care, emergency medicine. Abstracts must absolutely contain
Total Testing Process, including standardisation, preanaltical results.
process Statements such as “results will be
Toxicology, including therapeutic drug monitoring discussed” are not acceptable and will
Other lead to rejection.
28ABSTRACT SUBMISSION
Deadline for receipt
Abstracts should be submitted by 15th January 2019, 18:30 CET.
Confirmation of receipt
Receipt of the abstract will be acknowledged by e-mail immediately after submission.
Notification of acceptance or rejection
Authors will be notified of acceptance or rejection before 28th February 2019.
Registration
The presenting author of each abstract must register for the congress with “Full Registration”.
HOW TO PREPARE AND SUBMIT AN ABSTRACT
It is important to carefully follow the instructions below. Incorrectly prepared abstracts will be rejected.
■ Abstracts should be prepared off-line in advance;
■ Prepare your abstract on a word processor (such as Microsoft Word);
■ Do not include title, authors’ names and affiliations in the abstract file
■ Tables and figures are not allowed;
■ References are not allowed;
■ When abbreviations are used, spell out the full word at first mention in the text followed by the abbreviation in parentheses.
Thereafter, use the abbreviation throughout.
When the on-line system requires the abstract to be entered, copy and paste your text.
Abstracts are limited to 2300 characters, spaces included (title, authors’ names and affiliations excluded). The system will automatically
notify you if the abstract exceeds this number of characters.
Title, author(s) and affiliation(s) must be added separately at the appropriate step.
IMPORTANT NOTICE
Abstract authors are asked to indicate the most suitable topic for presentation of their work and will also be asked whether they wish
apply for an oral presentation during the scientific symposia. In that case, authors must also select the symposium in which they would
like to give their presentation.
Abstracts should be submitted via the on-line submission system only.
Do not send in an abstract more than once!
Submit your abstract at
http://www.euromedlab2019barcelona.org
29CONGRESS VENUE
CCIB - CENTRE CONVENCIONS INTERNACIONAL DE BARCELONA
PLAÇA DE WILLY BRANDT, 11-14
08019 BARCELONA, SPAIN
International Convention Centre is an integral part of Diagonal Mar, the newest section of Barcelona’s seafront.
This also places the CCIB in the heart of the technology and business district known as Barcelona 22@.
HOW TO GET TO CCIB
From and to the airport
The international airport, Aeroport del Prat, is located 13 km south-west of Barcelona and 20 km from the CCIB.
The highway C-31 directly connects the airport with Barcelona.
To enter the city, the most direct routes to the city center are Avinguda Diagonal and Gran Via and also Ronda de Dalt and Ronda
Litoral, which surround the city.
Aerobus Taxi Urban Public transport
The bus service between the airport and The taxi ride takes The best options for traveling within the urban area of
the center of Barcelona (Plaça Catalunya) about 20 minutes. Barcelona are: train, bus, metro and tram.
runs from 6:00 to 1:00 (to Barcelona) and The rates change Next to Plaça Catalunya there is Urquinaona station or
from 5:30 to 0:15 (to the airport) every day. depending on the the metro yellow line (L4) that leads directly to the CCIB
The bus frequency is one every 10-12 schedule. by Maresme-Forum station. You can also get to the CCIB
minutes and the journey time is around 30 by bus: lines 7, H16 and tram: Forum station.
minutes. All these means of transport leave you just few minutes
away from the CCIB by foot.
30GENERAL INFORMATION
REGISTRATION DESK
The registration desk will be open during the congress as follows:
19 May 2019 11:00 - 19:00
20 May 2019 08:00 - 18:00
21 May 2019 08:00 - 18:00
22 May 2019 08:00 - 18:00
23 May 2019 08:30 - 14:00
CONGRESS LANGUAGE
The congress’ official language is English.
NAME BADGE
A name badge will be required for access to the congress area. Participants will receive a name
badge when they check in at the registration desk. It must be worn at all times.
INDUSTRY EXHIBITION
Participants are encouraged to visit the large industry exhibition, which will be open as follows:
20 May 2019 10:00 - 17:30
21 May 2019 10:00 - 17:30
22 May 2019 10:00 - 17:30
Access to the exhibition area is free of charge for participants registered to the congress.
All the other visitors will be given the possibility to print a free visitor badge in advance or to collect it at a dedicated desk situated at the
entrance of the area.
CERTIFICATE OF ATTENDANCE
A certificate of attendance will be issued to properly registered attendees, for the day(s) they actually take part in the congress. Certificates
of attendance must be picked up at the registration desk just before departure.
VISAS REQUIREMENTS
Depending on the nationality of the delegates it may be necessary to obtain a visa before leaving. In this case, they should apply to the
Spanish consulate in their country. Details of the addresses can be found at this link
https://www.justlanded.com/english/Spain/Visas-Permits
INVITATION LETTER
An official letter of invitation will be sent to you upon request. The invitation letter may be used by
visitors to raise travel funds or to obtain a visa, but is not a commitment on the part of the organisers to provide any financial support.
Please contact the Organising Secretariat, info@euromedlab2019barcelona.org, to request a letter of invitation.
CATERING SERVICE
Several areas selling food will be open to all delegates, exhibitors and visitors inside the congress centre.
31REGISTRATION FEES
All delegates must register for the congress. Registration fees are as follows:
until 31 March 2019
Full Registration €670,00 (vat included)
Young Registration (≤35 years) €335,00 (vat included)
Day Registration €305,00 (vat included)
After 31 March 2019
Full Registration €850,00 (vat included)
Young Registration (≤35 years) €455,00 (vat included)
Day Registration €365,00 (vat included)
On-site registration
Full Registration €910,00 (vat included)
Young Registration (≤35 years) €485,00 (vat included)
Day Registration €425,00 (vat included)
The full registration and young registration fees include:
• entrance to plenary lectures, symposia, industry-sponsored workshops, posters sessions and exhibition
• possibility to submit abstracts
• certificate of attendance
• coffee and tea service during intermissions
• Opening Ceremony (Sunday, 19 May 2019)
• Closing Ceremony (Thursday, 23 May 2019)
The day registration fee includes, for the day of registration only:
• entrance to plenary lectures, symposia, industry-sponsored workshops, posters sessions and exhibition
• certificate of attendance
• coffee and tea service during intermissions
REMITTANCE
Registration fees shall be paid by credit card or bank transfer through the on-line system available
on the congress web site.
When paying by bank transfer, a copy of the transfer receipt must be sent by fax (+39 02 668 6699). Registrations without proof of
payment will not be accepted.
On-site registrations may be paid only by credit card or cash. Cheques will not be accepted.
The organising secretariat will send registration receipt upon receipt of payment, via e-mail. Be
sure your e-mail address is filled in correctly.
32REGISTRATION FEES
PERSONAL INVITATION FOR VISA PURPOSES
To facilitate congress attendance a personal invitation can be sent on request. This invitation
does not exempt the recipient from registering and paying the proper congress fee. Please inform
the congress secretariat if you need a personal invitation letter.
CURRENCY
Registration fees and charges for all events related to the Euromedlab Barcelona 2019 Congress as well as hotel cost must be paid in
euros.
CANCELLATION AND REFUND
Cancellations must be sent in writing to registrations@euromedlab2019barcelona.org.
The amount equal to 80% of the fee paid will be refunded for cancellations received by 30 March 2019.
Until 30 April, 2019 a refund of 50% of the fee will be granted. After 30 April 2019 no refunds will be issued.
All refunds will be paid in euros after the congress.
CANCELLATION OF THE CONGRESS
The congress secretariat reserves the right to cancel the congress, shift venue, or change dates
without notice, in case of “force majeure”.
Neither MZ Congressi nor the Congress Organising Committee shall be liable for any damage claims.
LIABILITY AND INSURANCE
Registration fees do not include the insurance of participants against personal accidents, sickness
and cancellations by any party, theft, loss or damage to personal possessions. Participants are
advised to take out adequate personal insurance to cover travel, accommodation, cancellation and
personal effects.
On-line registration is available on the congress website
http://www.euromedlab2019barcelona.org
Registration can be submitted on-line only
33HOTEL INFORMATION
KENES GROUP is the officially appointed
Housing Agency for IFCC/ Euromedlab 2019 Barcelona.
Ms.Irina Sapir - isapir@kenes.com
Phone: +41 22 908 0488 | Ext. 998
Hotel Sales Manager
SELECTION OF HOTELS
After consultation with the organisers, Kenes Group has selected a series of Barcelona hotels for you, at various categories
(three- to five-star).
KENES WEBSITE FOR ONLINE INDIVIDUAL BOOKINGS (up to 5 rooms)
A special hotel booking system for the Euromedlab Barcelona 2019 Congress has been created.
Individual reservations for up to five rooms can be made through the fully secured Kenes website.
You will find a comprehensive description of each hotel, including photos, map and distance to the venue.
You will be able to book your hotel room online and receive direct confirmation.
GROUP RESERVATIONS (6 ROOMS OR MORE)
Group reservations for six rooms or more must be specially requested. Please email your exact request to Irina Sapir
at isapir@kenes.com, stating number of rooms, arrival and departure dates, room type (single or double), preferred hotel
and/or location, and maximum room rate.
A tailor-made offer will be sent to you within two working days of the receipt of your request.
34PLATINUM GOLD SILVER BRONZE
IS YOUR LABORATORY
REACHING ITS TRUE
POTENTIAL?
Performing labs deliver results
that drive better patient outcomes
and improve healthcare value
Recognizing the challenges facing healthcare and
clinical diagnostics, we at Abbott have been on a Clinical
Chemistry
journey to deliver solutions that are personalized Alinity c
to your goals. Alinity is Abbott’s next-generation Informatics Immunoassay
Alinity PRO Alinity i
holistic family of systems, designed to simplify
diagnostics and deliver unprecedented integration
across key laboratory disciplines, helping you
Hematology
achieve measurably better healthcare performance. Point of Care Alinity hs
i-STAT Alinity Alinity hq
For more information, please visit Alinity.com,
ask your local Abbott Ambassador, or send an
Molecular Transfusion
email: wired@abbott.com Alinity m Alinity s
CHOOSE TRANSFORMATION
ADD-00063263_EN
Clinical Chemistry | Immunoassay | Hematology | Transfusion | Molecular | Point of Care | Professional ServicesYou can also read
